Hepatitis B immune globulin: The US experience

Clinical Transplantation

Volumn 14, Issue SUPPL. 2, 2000, Pages 7-13

  Pruett, T L ^a   McGory, R ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Antibody; HBlg; Hepatitis B; Lamivudine; Liver; Transplantation

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HYPERIMMUNE GLOBULIN; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; MONOCLONAL ANTIBODY; VIRUS DNA;

ALLOGRAFT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GRAFT INFECTION; GRAFT REJECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PASSIVE IMMUNIZATION; PATIENT SELECTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; UNITED STATES; VIRUS REPLICATION;

ANTIVIRAL AGENTS; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LAMIVUDINE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MUTATION; PATIENT SELECTION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES; VIRUS REPLICATION;

EID: 0033852023     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization
2. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization
3. Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIg) prophylaxis after liver transplantation
4. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin
5. Recurrent hepatitis B virus (HBV) infection in patients receiving hepatitis B immunoglobulin (HBIg) prophylaxis after liver transplantation (LT): Predictive value of circulating HBV DNA by polymerase chain reaction (PCR)
6. European hepatitis B immunoglobulin trials: Prevention of recurrent hepatitis B after liver transplantation
7. Hepatitis B virus (HBV) re-infection following liver transplantation: Theory and practice
8. Liver transplantation for hepatitis B cirrhosis: Clinical sequela of passive immunization
9. Should liver transplantation be performed for patients with chronic hepatitis B?
10. Mercury poisoning associated with hepatitis-B immunoglobulin (letter)
11. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients
12. Initial patient experience with an intravenous hepatitis B immune globulin
13. Liver transplantation for HBV-related disease under immunosuppression with tacrolimus: An experience with 78 consecutive cases
14. Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression
15. Retransplantation in hepatitis B - A multicenter experience
16. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft
17. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin
18. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis
19. Management of hepatitis B virus infection in liver transplant recipients: Prospects and challenges
20. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin